| Joseph Michael Ripperger, MD | |
|
2201 Westpark Dr, Norman, OK 73069 | |
| (405) 579-4111 | |
| (405) 579-4223 |
| Full Name | Joseph Michael Ripperger |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 35 Years |
| Location | 2201 Westpark Dr, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578510244 | NPI | - | NPPES |
| 100171670A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 17320 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norman Psychiatry Aprn-cnp Pllc | 3971866484 | 9 |
News Archive
Enhancers are regulatory elements that play an important role in cancer.Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, identified a novel enhancer.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
Nextrials, Inc., a leader in clinical research software and services, will participate in an integration demonstration between its PrismTM, an award-winning clinical trial electronic data capture technology, and electronic health records (EHR) platforms used within healthcare systems at the 11th Annual IHE North America Connectathon, being held January 11-15 at the Hyatt Regency Chicago. The Connectathon is the healthcare IT industry's largest interoperability testing event dedicated to establishing standards that address specific clinical needs in support of optimal patient care.
› Verified 5 days ago
| Entity Name | Norman Psychiatry Aprn-cnp Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043728587 PECOS PAC ID: 3971866484 Enrollment ID: O20180416002406 |
News Archive
Enhancers are regulatory elements that play an important role in cancer.Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, identified a novel enhancer.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
Nextrials, Inc., a leader in clinical research software and services, will participate in an integration demonstration between its PrismTM, an award-winning clinical trial electronic data capture technology, and electronic health records (EHR) platforms used within healthcare systems at the 11th Annual IHE North America Connectathon, being held January 11-15 at the Hyatt Regency Chicago. The Connectathon is the healthcare IT industry's largest interoperability testing event dedicated to establishing standards that address specific clinical needs in support of optimal patient care.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Michael Ripperger, MD 2201 Westpark Dr, Norman, OK 73069-4012 Ph: (405) 579-4111 | Joseph Michael Ripperger, MD 2201 Westpark Dr, Norman, OK 73069 Ph: (405) 579-4111 |
News Archive
Enhancers are regulatory elements that play an important role in cancer.Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, identified a novel enhancer.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
Nextrials, Inc., a leader in clinical research software and services, will participate in an integration demonstration between its PrismTM, an award-winning clinical trial electronic data capture technology, and electronic health records (EHR) platforms used within healthcare systems at the 11th Annual IHE North America Connectathon, being held January 11-15 at the Hyatt Regency Chicago. The Connectathon is the healthcare IT industry's largest interoperability testing event dedicated to establishing standards that address specific clinical needs in support of optimal patient care.
› Verified 5 days ago
Limei Yang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15951 Little Axe Dr, Norman, OK 73026 Phone: 405-447-0300 Fax: 405-701-7914 | |
Mrs. Dinah Bess L'heureux, PA-C Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2770 Washington Dr Ste 100, Norman, OK 73069 Phone: 405-310-3735 Fax: 405-310-3576 | |
Charito Marcelo, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 320 12th Ave Ne, Norman, OK 73071 Phone: 405-573-3821 Fax: 405-573-8256 | |
Dr. Lori Lynn Hake, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-321-4880 Fax: 405-573-6684 | |
Kanika Manne, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-573-6602 | |
Uzma Zaidi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-573-6602 Fax: 405-573-6684 | |
Dr. Thomas Lee Mcneil, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 N Porter Ave, Suite 212, Norman, OK 73071 Phone: 405-329-5255 Fax: 405-329-5244 |